Low Glomerular Filtration Rate, Recurrent Stroke Risk, and Effect of Renin-Angiotensin System Modulation [Brief Reports]
Conclusions—
Low eGFR is independently associated with a higher risk of recurrent stroke, but short-term add-on telmisartan therapy does not seem to mitigate this risk.
Clinical Trial Registration—
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00153062.
Source: Stroke - Category: Neurology Authors: Ovbiagele, B., Bath, P. M., Cotton, D., Sha, N., Diener, H.-C., for the PRoFESS Investigators Tags: Secondary prevention, Pathophysiology, Risk Factors, Other diagnostic testing, Other Stroke Treatment - Medical Brief Reports Source Type: research
More News: Clinical Trials | Databases & Libraries | Hypertension | Ischemic Stroke | Neurology | Stroke | Women